Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05486312 · ClinicalTrials.gov registry record · NA
7-week Study With CT-155 in People With Schizophrenia
A NA study, sponsored by Click Therapeutics.
- Completed
- Registry status
- NA
- Development phase
- 72
- Enrollment target
NCT05486312 is a NA study that has completed, run by Click Therapeutics. The registered enrollment target is 72 participants.
The verdict
NCT05486312, a NA study, has completed, sponsored by Click Therapeutics.
- COMPLETED
- Registry status
- NA
- Development phase
- 72 participants
- Enrollment target
Study Summary
CT-155 is a novel prescription digital therapeutic (PDT) to treat schizophrenia
Interventions
- DEVICE CT-155 smartphone app
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 72 participants |
| Start Date | 2022-07-05 |
| Est. Completion | 2022-12-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05486312
The ClinicalTrials.gov registry entry for NCT05486312 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 72 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Click Therapeutics, which has 15 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which CT-155 smartphone app is the first listed.
NCT05486312 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05486312 about?
NCT05486312 is a clinical study titled "7-week Study With CT-155 in People With Schizophrenia". CT-155 is a novel prescription digital therapeutic (PDT) to treat schizophrenia
What is the current status of trial NCT05486312?
This trial is currently completed. It is a NA study. The enrollment target is 72 participants. The study started on 2022-07-05. Estimated completion is 2022-12-12.
What interventions are being tested in trial NCT05486312?
The interventions under investigation include: CT-155 smartphone app (DEVICE).
Who is sponsoring clinical trial NCT05486312?
This trial is sponsored by Click Therapeutics, which has 15 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.